BBS-Bioactive Bone Substitutes
0,054
EUR
BONEH
First North Finland
Medical Equipment & Services
Health Care
3.934 følger denne virksomhed
-8,5%
-17,23%
+1,51%
-42,27%
-86,11%
-90,9%
-97,11%
-97,73%
-98,12%
BBS-Bioactive Bone Substitutes is a medical technology company. The company designs, develops and constructs biological implants for patients with bone defects and healing problems. The company's solutions are resold under the Artebone brand and are based on tricalcium phosphate (TCP) and bone protein, which stimulates the bone healing process. The company was founded in 2003 and is headquartered in Oulu.
Læs mereMarkedsværdi
1,51 mio. EUR
Aktieomsætning
-
P/E (adj.) (24e)
-0,4
EV/EBIT (adj.) (24e)
-2,1
P/B (24e)
0,48
EV/S (24e)
697,38
Udbytteafkast, % (24e)
-
Omsætning og EBIT-margin
Omsætning t
EBIT-% (adj.)
EPS og udbytte
EPS (adj.)
Udbytte %
Finanskalender
29.4
2025
Generalforsamling '25
29.8
2025
Delårsrapport Q2'25
Risiko
Business risk
Valuation risk
Lav
Høj
ViserAlle indholdstyper
BBS-Bioactive Bone Substitutes Plc - Insider information: BBS-Bioactive Bone Substitutes Plc has been declared bankrupt
BBS-Bioactive Bone Substitutes Plc - Insider information: BBS-Bioactive Bone Substitutes Plc Files for Bankruptcy
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
BBS-Bioactive Bone Substitutes Plc: Situational information about measures to be taken to secure the company's financial situation and operations
BBS-Bioactive Bone Substitutes Plc: Financial manager Annastiina Kauppinen resigns from the Company
BBS-Bioactive Bone Substitutes Plc: The Finnish Financial Supervisory Authority has imposed a penalty payment on a two current and one former member of Company’s Board of Directors
Correction: BBS-Bioactive Bone Substitutes Oyj – Insider information: CEO Juliusz Rakowski has terminated the CEO agreement
BBS-Bioactive Bone Substitutes Oyj – Changes in the Management team: CEO Juliusz Rakowski has terminated the CEO agreement
BBS-Bioactive Bone Substitutes Plc: Financial calendar and Annual General Meeting in 2025
BBS-Bioactive Bone Substitutes Plc – Insider information: The results of change negotiations
